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MINI REVIEW
TLR8: the forgotten relative revindicated
Jorge L Cervantes1, Bennett Weinerman1, Chaitali Basole1 and Juan C Salazar1,2,3
The endosomal Toll-like receptors (TLRs) TLR3, TLR7, TLR8 and TLR9 are important in sensing foreign nucleic acids encountered by
phagocytes. Because TLR8 was initially thought to be non-functional in mice, less is known about TLR8 than the genetically and
functionally related TLR7. Originally associated with the recognition of single-stranded RNA of viral origin, there is now evidence that
human TLR8 is also able to sense bacterial RNA released within phagosomal vacuoles, inducing the production of both nuclear factor
(NF)-kB-dependent cytokines and type I interferons (IFNs), such as IFN-b. The functions of TLR8 extend beyond the recognition of
foreign pathogens and include cross-talk with other endosomal TLRs, a process that may also have a role in the generation of
autoimmunity.
Cellular & Molecular Immunology (2012) 9, 434–438; doi:10.1038/cmi.2012.38; published online 22 October 2012
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INTRODUCTION
Over the past two decades, our understanding of the innate immune
system has increased exponentially,1–3 and the role of Toll-like recep-
tors (TLRs) in pathogen sensing has been at the forefront of innate
immunity research. TLRs are transmembrane pattern recognition
receptors capable of recognizing generic pathogen-associatedmolecu-
lar patterns (PAMPs) and danger-associatedmolecular patterns. Their
activation induces intracellular signaling pathways that result in pro-
duction of inflammatory cytokines as well as type I interferons (IFNs).
TLRs are composed of an ectodomain containing leucine-rich repeats
that facilitate PAMP recognition, a transmembrane domain and the
intracellular Toll IL-1 receptor (TIR) domain which enables down-
stream signal transduction.2
There are 10 known functional TLRs in humans and 12 in mice;3
TLRs 1–9 are conserved in both species.3 Each TLR is associated with
the recognition of specific PAMPs, and the response that ensues upon
their activation is dependent upon the particular pathogen and the
immune cell subtype involved.4 TLR-mediated recognition of its cog-
nate PAMPs can occur at the plasma membrane or at endosomal and/
or endolysosomal membranes.2 TLR1, 2, 4, 5, 6 and 11 are primarily,
although not exclusively, expressed on the plasma membrane of
immune cells. These TLRs recognize a variety of unique microbial
membrane components like lipids, lipoproteins and proteins.
Conversely, TLR 3, 7, 8 and 9 are expressed on intracellular vesicular
membranes and are commonly involved in recognition of nucleic
acids (Figure 1).5 Besides the endosomal TLRs, several other nucleic
acid sensing systems have been characterized in the cytosol. These
include the retinoic acid-inducible gene I, and retinoic acid-inducible
gene I-like receptors melanoma differentiation-associated protein 5,
and LGP2, which are capable of recognizing RNA of different struc-
tures,6,7 and the pyrin and HIN domain-containing protein family
member absent in melanoma (AIM2) which senses dsDNA.8,9 The
signal transduction pathways activated by these pattern recognition
receptors are quite well characterized, and will not be discussed in this
review.
Until recently, very little attentionwas paid to TLR8, as this TLRwas
initially considered to be inactive inmice.10 Several recent reports have
demonstrated that TLR8 is not only involved in the production of type
I IFNs in response to viral pathogens, but also triggered upon ligation
of bacterial RNA.11–14
ENDOSOMAL TLRS
The prototypical intracellular TLRs (TLR3 and TLR7–9) are generally
associated with sensing nucleic acids released within endosomal com-
partments. Their activation leads to the production of a variety of
nuclear factor (NF)-kB-mediated cytokines (i.e. tumor necrosis fac-
tor) and type I IFNs.6 TLR3 recognizes double-stranded RNA and
double-stranded RNA synthetic analogs (poly I:C).3 The genes which
code for TLR7 and TLR8 are located in the X chromosome. TLR7 and
TLR8 are phylogenetically similar15 and both are capable of recog-
nizing single-stranded RNA and short double-stranded RNA,16 hence
their role in sensing different viral pathogens.17 TLR7 and TLR8 can
also detect oligoribonucleotides and a variety of synthetic chemical
agonists such as imidazoquinolines.15,18,19 TLR9, by contrast, recognizes
non-methylated 29-(cytidine-phosphate-guanosine) DNAmotifs which
are present in some viruses and bacteria.3,20
TLR8 is known to be primarily expressed in monocytes/macro-
phages and myeloid dendritic cells (DCs),21,22 while TLR7 is predo-
minately expressed in plasmacytoid DCs and, to some extent, in B cells
andmonocytes/macrophages.15,22 There isminimal or absent express-
ion of TLR9 in monocytes, so their endosomal TLR profile constitutes
essentially the opposite of that of DCs.15,22
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Shuttling of the TLR from the endoplasmic reticulum compartment
to the endosome is now considered to be critical for their activation.23
Recent evidence suggests that endosomal TLRs are delivered from the
endoplasmic reticulum to the endosome by the endoplasmic reticu-
lum-resident membrane protein UNC93B1.24,25 In the case of TLR8,
UNC93B1 appears to be required not only for intracellular trafficking,
but also for cell signaling.25 After activation by its cognate ligands,
TLR8 is modified to yield species of different molecular mass, inclu-
ding a monoubiquitinated form which might serve as a cell signal for
trafficking in the endocytic pathway.23 Attachment of monoubiquitin
to membrane proteins serves a signal for internalization of the TLR
into the endosome, the site of active signaling.
TLR8 IS ACTIVATED BY BACTERIAL RNA
While the role of TLR7 in sensing bacterial RNA is now well
accepted,26,27 a similar role for TLR8 has only began to be uncovered.
Using TLR7 and TLR8 stably transfected HEK cell lines, it was pre-
viously shown that Escherichia coli total RNA induced activation of
TLR7 and TLR8.28 Two relatively recent studies suggested that bac-
terial nucleic acids could induce TLR8 activation. In the first study,
TLR8 was upregulated following phagocytosis ofMycobacterium bovis
by THP-1 cells.11 In the same study, the investigators showed that
there was an association of TLR8 gene variants with susceptibility to
pulmonary tuberculosis. In the second study, phagocytosis of
Helicobacter pylori by THP-1 cells induced TLR8 activation.12 We
recently showed that phagocytosis of live Borrelia burgdorferi, the
spirochetal bacterial agent of Lyme disease, induced transcription of
IFN-b29 and that this phenomenon was entirely dependent on the
availability of TLR8,13 while induction of NF-kb-dependent cytokines
was due to a cooperative action of TLR2 and TLR8. More recently, we
provided ex vivo evidence that TLR8 activation is triggered by recog-
nition of borrelial RNA delivered to endosomal vacuoles.14 In these
same studies, we demonstrated that in highly purified human mono-
cytes, TLR8 is self-amplifying and solely responsible for induction of
IFN-b through IRF-7 (Figure 1),13 a similar signaling pathway as-
sociated with recognition of RNA viruses.30
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Figure 1 TLR signaling overview: the TLR family can be subdivided into two categories. TLR1, TLR2, TLR4, TLR5 and TLR6 are located primarily on the cell surface.
Conversely, TLR3, TLR7, TLR8 and TLR9 are located within intracellular vesicles. Furthermore, TLRs can be found as homo or heterodimers (such as TLR1/2 and
TLR2/6). Upon recognition of a PAMP, the TLR changes its conformation and recruits adapter proteins such as TRIF, TRAM, MyD88 and TIRAP. The cell surface
TLRs, including the heterodimers TLR1/2 and TLR2/6, recruit MyD88 and TIRAP adaptor proteins to signal theNF-kb pathway to produceNF-kb-mediated cytokines.
Additionally, TLR4 uses the TRIF and TRAMproteins to produce type I IFNs through the IRF3 pathway. Of the endosomal TLRs, TLR8 and TLR9 utilize adaptor protein
MyD88 to signal through NF-kb and IRF7 pathways. Finally, endosomal TLR3 enlists the TRIF adaptor to create both type I IFNs as well as NF-kb cytokines through
IRF3 and NF-kb pathways. The model depicts internalization of an extracellular pathogen, Borrelia burgdorferi (Bb), which is internalized into the phagosome where
TLR2 and TLR8 signalling occurs. Phagocytosis of live Bb, induces transcription of IFN-b through IRF-7, a phenomenon entirely dependent on the availability of TLR8,
while induction of NF-kb-dependent cytokines is due to a cooperative action of TLR2 and TLR8.10 IFN, interferon; IRF, IFN regulatory factor; PAMP, pathogen-
associated molecular pattern; NF, nuclear factor; TLR, Toll-like receptor.
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Bacterial ribosomal RNA appears to be the major stimulatory frac-
tion to elicit production of IFN-a response by human peripheral blood
mononuclear cells,27 although transfer RNA from some bacteria may
also induce production of IFN-a through TLR7 activation.31
MURINE TLR8 ACTIVATION
Though mouse and human TLR8 are highly related, they have shown
differential receptor specificity both to natural/physiological and to
synthetic TLR ligands.10,32 Historically, murine TLR8 was thought to
be non-functional as it was initially observed that TLR72/2 mice did
not respond to the TLR7/8 agonist R848,10 or TLR8 RNA ligands.33
However, when murine peripheral blood mononuclear cells were
treated simultaneously with TLR8 selective imidazoquinoline 3M-
002 and polyT oligonucleotides, enhanced TLR8 activation and sup-
pression of TLR7 was observed.34 A recent report provided evidence
that TLR8 can be activated in murine plasmacytoid DCs by vaccinia
virus DNA, an A/T rich DNA virus.35 This finding is controversial not
only because DNA has not been previously linked to TLR8 activation,
but also because murine plasmacytoid DCs are generally known to
express TLR7 and TLR9, and not TLR8.36
TLR CROSS-TALK
Several investigators have shown that responses to viral and bacterial
pathogens are not merely dependent on activation of individual TLRs,
but instead by complex TLR–TLR interactions.37,38 Synergistic effects
have been observed between endosomal TLRs, like augmentation of
NF-kb and IFN regulatory factor (IRF) activation, when monocyte-
derived macrophages and DCs are stimulated concomitantly with
TLR8, as well as with TLR3 and TLR4 ligands.37,39 TLR8 may also
act synergistically with intracellular pattern recognition receptors,
such as nucleotide oligomerization domain receptor to induce inflam-
matory cytokine production.40
In line with this idea, we have provided evidence that TLR2 expres-
sion is upregulated following TLR8 activation in human monocytes14
(Figure 2), a phenomenon occurring possibly through an IFN-b auto-
crine/paracrine effect.20 A similar phenomenon has been observed in
THP-1 cells, where preexposure to the TLR8 ligand 3M-002, increased
the response to subsequent stimulation with TLR2 ligands.41
The TLR7/8 ligand R848 also increases expression of CD14 in
monocytes as they differentiate into DCs.42 This is an important fin-
ding because CD14 facilitates TLR2-dependent signaling by bacterial
lipoproteins.43–45 Upregulation of TLR2 and TLR8 also has been
associated with enhanced clearance of human papillomavirus infec-
tion.46 All this evidence suggests beneficial implications in the use of
TLR7/8 agonists as vaccine adjuvants.
Human TLR8 inhibits TLR7 and TLR9 activation, and murine
TLR8 also inhibits TLR7 activation47 (Figure 2). TLR8 deficiency leads
to overexpression of TLR7 in murine DCs with increased NF-kb
activation and development of autoimmunity.48 In humans, TLR7
and TLR9 are upregulated in patients with Sjogren’s syndrome, while
TLR8 is not.49
TLR8 SPLICE VARIANTS
Given that TLR8 appears to play a role in the sensing of phagocytosed
bacteria, TLR8 SNPs could alter or modulate TLR8 function. The
TLR8 gene locus encodes for two splice variants (TLR8v1 and
TLR8v2) with alternative translation start sites.50,51 Their proteins
differ in 19 additional amino acids in the N-terminus of TLR8v1. A
third missense variant, termed G or A1G allele of TLR8 (rs3764880),
affects the coding region of TLR8v2, rendering a truncated form.12
While all three variants appear to exhibit similar function,12 TLR8v2 is
the most conserved form of TLR8 amongst primates and seems to be
the prevalent form of TLR8 expressed in human monocytes.12 The
effect of rs3764880 appears to be mostly related to changes of Kozak
context, which reduce the amount of TLR8 which is generated.12
Interestingly, phagocytosis of H. pylori by THP-1 monocytic cells
results in significant upregulation of the two main TLR8 variant
mRNAs.12 The attenuated form of M. bovis, also known as bacille
Calmette-Gue´rin, is also able to induce TLR8 protein expression in
the same cell line, when located in the phagosome.11 Mycobacterium
tuberculosis has been reported to induce both TLR8 variant mRNAs in
the blood of patients with active TB.11 The A allele of the TLR8 poly-
morphism rs3764880 was associated with increased susceptibility to
pulmonary tuberculosis, while its allele G was associated with protec-
tion against active tuberculosis.11 A decrease in TLR8v2 translation seen
with the G allele of rs376488012 may imply a decrease in TLR8 sensing
and activation. Protection against HIV-1 and TB disease progression,
which has been observed in patients with this TLR8 allele11,52 could be
due to a resultant lesser inflammatory response. HIV-1 replication in
human DCs may require TLR8-dependent NF-kb activation,17 and in
the case of M. tuberculosis, compromised phagosomal sensing would
translate into a limited immune response. Lastly, TLR8v1, appears to be
involved in the positive regulation of TLR8 function in CD161CD141-
differentiated monocytes,12 a subset of differentiated human mono-
cytes with enhanced proinflammatory properties.53
TLR-8 AGONISTS
TLR8 agonists are attractive targets for use as vaccine adjuvants, due to
their efficiency in activating inflammatory immune responses.54 The
use of R848 (Resiquimod) is effective at activating local immune res-
ponses,55 and CL075, a specific TLR8 agonist, stimulates the genera-
tion of inflammatory monocyte-derived DCs.56 There is promising
therapeutic potential of TLR8 agonists in cancer, aiming to induce
an immune response to tumors and improve clinical responses to
clinically approved monoclonal antibody therapies, especially in indi-
viduals who show reduced antibody-dependent cell-mediated cyto-
toxicity activity. A number of endosomal TLR agonists are being tested
for their potential to enhance antitumor immunity.57 Recently a new
TLR8 agonist (VTX-2337) that activates monocytes, DCs and natural
killer cells was shown to increase IFN-c production, cytolytic activity,
and to enhance rituximab-mediated antibody-dependent cell-mediated
(14,41)
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(47)
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Figure 2 Regulatory effects of TLR8: human TLR8 downregulates TLR7 and
TLR9 signalling. Similarly murine TLR8 inhibits TLR7.47 Conversely TLR8 can
upregulate TLR2 expression.14
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cytotoxicity, even in individuals with genotypes associated with a
reduced affinity for therapeutic monoclonal antibodies.58
Another TLR8 agonist (VTX-1463) is currently in development for
the treatment of allergic rhinitis.59 The basis for its use relies on the
induction of T helper 1 (Th1)-associated inflammatory mediators,
such as IL-12, IFN-c and monocyte chemotactic protein-1 after
TLR8 activation. By promoting TLR8 signaling, the cytokine response
may activate antigen presenting cells, thereby inducing a Th1 type
response.57 The induction of this Th1 type response aims to shift the
balance of the Th1/Th2 ratio in favor of a reduction in the allergic
reaction. Taking advantage of this inducible Th1 type response
through TLR8 activation, the use of an HIV vaccine where the HIV-
gag protein has been coupled with a TLR-7/8 agonists improves the
CD81 T cell response in rhesus macaques.60 Stimulation of TLR7/8 by
R-848 has been reported to suppress HIV-replication in cultured
monocytes.61
CONCLUSIONS
Bacterial nucleic acid sensing by intracellular innate immune receptors
is an important component of the host immune response to microbial
infections.26 Initially associated with the recognition of single-
stranded RNAof viral origin, herein we have summarized the evidence
that human TLR8 is also able to sense bacterial RNA.11–14 Bacterial
RNA constitutes a viability-associated PAMP (vita PAMP),62 in con-
trast to its naked ligand counterpart. Internalization and degradation
of bacteria in phagosomes, allows close interaction between bacterial
RNAwith endosomal TLR8. TLR8 in turn has the ability to upregulate
other TLRs and further modulate the immune response to bacterial
pathogens.
TLR-mediated recognition of bacterial ligands in the phagosome
promotes selection of bacterial antigens for optimal presentation on
MHC class II, and leads to the induction of costimulatory molecules
and cytokines necessary for activation and differentiation of T lym-
phocytes. This not only constitutes the basis for the use of TLR8
ligands as vaccine adjuvants,54 but explains the regulation of adaptive
immunity by the innate immune system,63 and the detrimental effect
of endosomal-TLR-mediated autoimmunity.64 The potential role of
TLR8 in the generation of a critical immune response against bacterial
infection and cancer has just begun to be uncovered.
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